Telesis Bio (Convertible Preferred Stock)
Funding Details
- Awarder
- Inbox
- Date Award
- May 18, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $21,000,000
Company Info
- Company Description
- Telesis Bio is a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries. The company empowers scientists to create novel, synthetic biology-enabled solutions for many of humanity's greatest challenges.
- Market
- Synthetic Biology
- Location
- San Diego, CA, USA
- Coinvestors
- Novalis LifeSciences, Northpond Ventures